Jan 15, 2021
News & Events
Press Releases
Jan 14, 2021
Salarius Pharmaceuticals Receives Second Installment of $1.7 Million in Payments from the Cancer Prevention and Research Institute of Texas
Dec 22, 2020
Salarius Pharmaceuticals to Participate in Biotech Showcase Digital and BIO @ JPM During “J.P. Morgan Week 2021”
Dec 11, 2020
Salarius Announces Exercise Of Warrants For $3.5 Million Of Gross Proceeds To Be Used For Ongoing Development Of Seclidemstat
Events
NobleCon17: Panel Discussion on Targeted Cancer Therapies
During the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, Dr. Daniela Santiesteban, Director of Research and Business Development at Salarius Pharmaceuticals, will participate in a virtual panel discussion highlighting the future of targeted cancer therapies. The panel...
Biotech Showcase Digital
https://informaconnect.com/biotech-showcase/registration-options/
A.G.P.’s Virtual Healthcare Symposium
Salarius Pharmaceuticals to Report Third Quarter 2020 Financial Results
Conference Call Information: Interested participants and investors may access the conference call by dialing either: (833) 423-0481 (U.S.) (918) 922-2375 (international) Conference ID: 1277839
In the News
Houston Business Journal